This study is for people with both HIV (a virus that affects the immune system) and AUD (Alcohol Use Disorder, a medical condition where someone has trouble controlling alcohol use). The study tests a medication that isn’t usually used for AUD, along with counseling from a pharmacist, to see if it helps reduce alcohol use. This is called "off-label" use because the medication is not specifically approved for AUD. The study lasts 12 weeks and involves several visits for interviews and tests. Participants will discuss their drinking habits and how ready they are to change. They will also complete some tests to see how much alcohol they consume.

Key Points:

• The study lasts 12 weeks and includes medication and counseling.
• You must have HIV, be over 18, and meet certain alcohol use criteria to join.
• Participants cannot be pregnant, have unstable health conditions, or be in current alcohol treatment.